+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Erythropoietin Drugs Market By Drug Class, By Product, By Application, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • ID: 5354429
  • Report
  • June 2021
  • Region: Asia Pacific
  • 81 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Amgen, Inc.
  • Biocon Limited
  • Celltrion, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Intas Pharmaceutical Ltd.
  • Johnson and Johnson
  • MORE
The Asia Pacific Erythropoietin Drugs Market is expected to witness market growth of 13.2% CAGR during the forecast period (2021-2027).

The increasing incidences of chronic diseases like cancer, end-stage renal diseases, and HIV are likely to boost the demand for EPO-stimulating agents. These diseases have the potential to cause anaemia. To control the increasing cases of anaemia, the demand for Erthropotin (EPO) drugs is expected to witness a surge in the forthcoming years.

The molecular weight of erythropoietin is about 30,400 daltons. It is generated by mammalian cells in which the gene of the human erythropoietin gene is introduced. The product acts similar to natural erythropoietin and retains biological activity in the same manner as endogenous erythropoietin. Epoetin alfa biosimilar like Retacrit (epoetin alfa-epbx or epoetin zeta) has a formulation that allows more treatment options for patients suffering from anaemia.

In the Asia Pacific, EPO industry is flourishing due to a continuous increase in the incidence of chronic diseases. There is high demand for low-cost therapeutics in this region. Therefore, the Asia Pacific has attracted many companies for the development of biosimilars. They are focused on developing more biosimilars than any other place on the globe.

Moreover, supportive government initiatives will also provide better health amenities to the public in this region. It is expected to contribute to the EPO drug market growth. For example, the Japanese government’s regulation stated that on the price of biosimilars, a discount of 30% should be given and making it available at subsidized prices to people who belong to the lower economic class.

The China market dominated the Asia Pacific Hematology Market by Country in 2020, thereby, achieving a market value of $191 million by 2027. The Japan market is showcasing a CAGR of 15.5% during (2021 - 2027). Additionally, The India market is poised to grow at a CAGR of 15.5% during (2021 - 2027).

Based on Drug Class, the market is segmented into Biologics and Biosimilars. Based on Product, the market is segmented into Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and others. Based on Application, the market is segmented into Renal Diseases, Cancer, Hematology and Neurology. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., F. Hoffmann-La Roche Ltd., Biocon Limited, Intas Pharmaceutical Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., LG Corporation (LG Life Sciences Ltd.), and Celltrion, Inc.

Scope of the Study

Market Segments covered in the Report:

By Drug Class
  • Biologics
  • Biosimilars
By Product
  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • others
By Application
  • Renal Diseases
  • Cancer
  • Hematology
  • Neurology
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Companies Profiled
  • Johnson and Johnson
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Biocon Limited
  • Intas Pharmaceutical Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • LG Corporation (LG Life Sciences Ltd.)
  • Celltrion, Inc.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen, Inc.
  • Biocon Limited
  • Celltrion, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Intas Pharmaceutical Ltd.
  • Johnson and Johnson
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Erythropoietin Drugs Market, by Drug Class
1.4.2 Asia Pacific Erythropoietin Drugs Market, by Product
1.4.3 Asia Pacific Erythropoietin Drugs Market, by Application
1.4.4 Asia Pacific Erythropoietin Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Erythropoietin Drugs Market by Drug Class
3.1 Asia Pacific Biologics Market by Country
3.2 Asia Pacific Biosimilars Market by Country

Chapter 4. Asia Pacific Erythropoietin Drugs Market by Product
4.1 Asia Pacific Epoetin-alfa Market by Country
4.2 Asia Pacific Epoetin-beta Market by Country
4.3 Asia Pacific Darbepoetin-alfa Market by Country
4.4 Asia Pacific Other Product Market by Country

Chapter 5. Asia Pacific Erythropoietin Drugs Market by Application
5.1 Asia Pacific Renal Diseases Market by Country
5.2 Asia Pacific Cancer Market by Country
5.3 Asia Pacific Hematology Market by Country
5.4 Asia Pacific Neurology Market by Country

Chapter 6. Asia Pacific Erythropoietin Drugs Market by Country
6.1 China Erythropoietin Drugs Market
6.1.1 China Erythropoietin Drugs Market by Drug Class
6.1.2 China Erythropoietin Drugs Market by Product
6.1.3 China Erythropoietin Drugs Market by Application
6.2 Japan Erythropoietin Drugs Market
6.2.1 Japan Erythropoietin Drugs Market by Drug Class
6.2.2 Japan Erythropoietin Drugs Market by Product
6.2.3 Japan Erythropoietin Drugs Market by Application
6.3 India Erythropoietin Drugs Market
6.3.1 India Erythropoietin Drugs Market by Drug Class
6.3.2 India Erythropoietin Drugs Market by Product
6.3.3 India Erythropoietin Drugs Market by Application
6.4 South Korea Erythropoietin Drugs Market
6.4.1 South Korea Erythropoietin Drugs Market by Drug Class
6.4.2 South Korea Erythropoietin Drugs Market by Product
6.4.3 South Korea Erythropoietin Drugs Market by Application
6.5 Singapore Erythropoietin Drugs Market
6.5.1 Singapore Erythropoietin Drugs Market by Drug Class
6.5.2 Singapore Erythropoietin Drugs Market by Product
6.5.3 Singapore Erythropoietin Drugs Market by Application
6.6 Malaysia Erythropoietin Drugs Market
6.6.1 Malaysia Erythropoietin Drugs Market by Drug Class
6.6.2 Malaysia Erythropoietin Drugs Market by Product
6.6.3 Malaysia Erythropoietin Drugs Market by Application
6.7 Rest of Asia Pacific Erythropoietin Drugs Market
6.7.1 Rest of Asia Pacific Erythropoietin Drugs Market by Drug Class
6.7.2 Rest of Asia Pacific Erythropoietin Drugs Market by Product
6.7.3 Rest of Asia Pacific Erythropoietin Drugs Market by Application

Chapter 7. Company Profiles
7.1 Johnson and Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals:
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Amgen, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.1 Financial Analysis
7.4.2 Segmental and Regional Analysis
7.4.3 Research & Development Expense
7.5 Biocon Limited
7.5.1 Company Overview
7.6 Intas Pharmaceutical Ltd.
7.6.1 Company Overview
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Dr. Reddy's Laboratories Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 LG Corporation (LG Life Sciences Ltd.)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.10. Celltrion, Inc.
7.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Johnson and Johnson
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Biocon Limited
  • Intas Pharmaceutical Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • LG Corporation (LG Life Sciences Ltd.)
  • Celltrion, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll